Volpara Enterprise DDP™ is now Volpara Scorecard™. Give your breast care team the insights they need to find cancer earlier. Improve clinical decision-making with three key breast density and risk insights in one view.
13.5 m+
Women across 39 countries have had their breast composition assessed by Volpara Health
The only
Volumetric breast density assessment validated for use with Tyrer-Cuzick 8
Science-based data and alerts when patients meet high-risk thresholds for additional detection or preventative care.
Volumetric density measurements validated for Tyrer-Cuzick 8, offering objective, precise, and consistent breast cancer risk assessment.
Integrated Tyrer-Cuzick 8 risk modeling calculates lifetime risk of developing breast cancer. *requires additional software purchase
AI and machine learning categorize mammograms by likelihood of cancer. *requires additional software purchase
Detailed product information and data sheet.